Enjoy your
FREE PREVIEW which shows only 2022 data and 25 documents. Contact
Patent Forecast for full access.
AI Biotech/Diagnostics: Cardio
Search All Applications in AI Biotech/Diagnostics: Cardio
Application US20190252079
Published 2019-08-15
System And Method For Decision Support
Systems and methods are provided to provide guidance to a user regarding management of a physiologic condition such as diabetes. The determination may be based upon a patient glucose concentration data sensed by a glucose concentration sensor. A host state change associated with the host glucose concentration data may be determined. A guidance message based at least in part on the host state change may also be determined. The guidance message may be delivered through a user interface.
Much More than Average Length Specification
View the Patent Matrix® Diagram to Explore the Claim Relationships
USPTO Full Text Publication >
- 1. A system comprising:
a glucose concentration sensor configured to detect a host glucose concentration; a communication circuit configured to receive the host glucose concentration from the glucose concentration sensor; a memory circuit including a stored model; and a processor configured to:
receive host glucose concentration data sensed by the glucose concentration sensor;
determine a host state change associated with the host glucose concentration data;
determine a guidance message based at least in part on the host state change; and
delivering the guidance message through a user interface.
- 10. A method of delivering physiologic glucose concentration management guidance comprising:
receiving a datum indicative of a glucose concentration; determining a patient state by applying the datum to a model; determining whether the patient state is atypical; determining a guidance message based on the atypicality of the patient state; and delivering the guidance message through a user interface.
- 18. A method of delivering physiologic glucose concentration management guidance comprising:
receiving a datum indicative of a glucose concentration; determining a patient state by applying the datum to a model; determining from the model that a low-probability state transition has occurred or is likely to occur; and delivering through a user interface a guidance message based on the determination that the low-probability state transition has occurred or is likely to occur.
- 28. A method of delivering physiologic glucose concentration management guidance comprising:
receiving a datum indicative of a glucose concentration; receiving one or more behavioral, environmental or contextual inputs; identifying a likely transition to an undesirable patient state by applying the datum and the one or more behavioral, environmental or contextual input to a model; determining a guidance message based on the likely transition to an undesirable patient state; and delivering the guidance message, wherein the guidance message is determined and delivered at a time such that the patient can intervene to avoid the transition to an undesirable patient state.
